| scholarly article | Q13442814 |
| P50 | author | David C. Christiani | Q30069760 |
| Geoffrey Liu | Q51134597 | ||
| P2093 | author name string | Li Su | |
| Wei Xu | |||
| Kofi Asomaning | |||
| Rebecca S Heist | |||
| Rihong Zhai | |||
| Zhaoxi Wang | |||
| Jessica Hopkins | |||
| Thomas J Lynch | |||
| John C Wain | |||
| Clement Ma | |||
| Penelope A Bradbury | |||
| Matthew J Kulke | |||
| P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
| Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
| Molecular determinants in targeted therapy for esophageal adenocarcinoma | Q33243542 | ||
| Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy | Q34157098 | ||
| Role of genetic polymorphisms in tumour angiogenesis | Q34981278 | ||
| Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk | Q37090696 | ||
| Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100. | Q37121685 | ||
| Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer | Q37326196 | ||
| Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter | Q40669979 | ||
| Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus | Q43998023 | ||
| Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial | Q45119068 | ||
| VEGF polymorphisms and survival in early-stage non-small-cell lung cancer | Q45288745 | ||
| Haplotype association analysis of discrete and continuous traits using mixture of regression models. | Q47228364 | ||
| A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels | Q48386340 | ||
| A rapid outcomes ascertainment system improves the quality of prognostic and pharmacogenetic outcomes from observational studies. | Q51896652 | ||
| Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. | Q52039628 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. | Q54507828 | ||
| Vascular endothelial growth factor gene polymorphisms in ovarian cancer | Q61853685 | ||
| Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression | Q73016350 | ||
| Expression of Vascular Endothelial Growth Factor as a Prognostic Factor in Node‐positive Squamous Cell Carcinoma in the Thoracic Esophagus: Long‐term Follow‐up Study | Q73317808 | ||
| Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production | Q74126993 | ||
| Angiogenesis in the neoplastic sequence of Barrett's oesophagus. Correlation with VEGF expression | Q74199749 | ||
| Demographic variations in the rising incidence of esophageal adenocarcinoma in white males | Q74373937 | ||
| Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival | Q79366646 | ||
| Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer | Q80140070 | ||
| Association of genetic polymorphisms in the VEGF gene with breast cancer survival | Q81856632 | ||
| Estimation and testing of genotype and haplotype effects in case-control studies: comparison of weighted regression and multiple imputation procedures | Q82639918 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| esophageal cancer | Q372701 | ||
| P304 | page(s) | 4680-4685 | |
| P577 | publication date | 2009-07-07 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis | |
| P478 | volume | 15 |
| Q37580616 | A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer p |
| Q58763391 | A systematic review and meta-analysis of prognostic biomarkers in resectable esophageal adenocarcinomas |
| Q35218636 | A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage |
| Q37858534 | Angiogenesis-related molecular targets in esophageal cancer |
| Q37716627 | Association between single nucleotide variants of vascular endothelial growth factor A and the risk of thyroid carcinoma and nodular goiter in a Han Chinese population |
| Q51567138 | Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction. |
| Q48587745 | Association of vascular endothelial growth factor--a gene polymorphisms and haplotypes with breast cancer metastases |
| Q44842420 | Associations between single-nucleotide polymorphisms of the VEGF gene and long-term prognosis of oral squamous cell carcinoma. |
| Q33943812 | Clinicopathological and prognostic significance of HER-2/neu and VEGF expression in colon carcinomas |
| Q52990210 | Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer. |
| Q85356854 | Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer |
| Q42749109 | DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy |
| Q41715428 | Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome. |
| Q33849608 | Fetal Vegf Genotype is More Important for Abortion Risk than Mother Genotype |
| Q33779432 | Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma |
| Q33659635 | Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy |
| Q57707731 | Impact of serum biomarkers on esophageal squamous cell carcinoma |
| Q38151816 | New therapeutic strategies for squamous cell cancer and adenocarcinoma |
| Q53062665 | Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer. |
| Q30514241 | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration |
| Q59822429 | Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration |
| Q37323407 | The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology. |
| Q82427987 | The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer |
| Q41083020 | VEGF Polymorphisms Related to Higher Serum Levels of Protein Identify Patients with Hepatocellular Carcinoma. |
| Q38148602 | VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update |
| Q35127114 | Variant alleles of VEGF and risk of esophageal cancer and lymph node metastasis |
Search more.